Pieters M N, Kramer H J, Slob W
National Institute of Public Health and the Environment (RIVM), Bilthoven, 3720 BA, The Netherlands.
Regul Toxicol Pharmacol. 1998 Apr;27(2):108-11. doi: 10.1006/rtph.1997.1196.
For the extrapolation of a subchronic no-observed-adverse-effect level (NOAEL) to a chronic NOAEL an uncertainty factor of 10 is routinely applied. We evaluated this uncertainty factor by statistically analyzing a database comprising 149 oral NOAEL(subchronic)/NOAEL(chronic) ratios. Since any database forms only a limited sample of all existent chemicals, we believe that estimation errors should be taken into account. Therefore, in addition to the 95th percentile (P95) of the ratio distribution, we calculated the 95% confidence interval (CI) of this percentile. The geometric mean (GM), geometric standard deviation (GSD), P95, and CI were 1.7, 5.6, 29, and 20-46, respectively. These data do not support a lowering of the uncertainty factor as has been suggested by others. Furthermore, we analyzed the LOAEL/NOAEL ratio for subacute, subchronic, and chronic toxicity studies. However, the size of the LOAEL/NOAEL ratio only depends on the spacing between doses of the studies reviewed. Therefore, though the results may be considered supportive for an uncertainty factor of 10, we believe that there is no justification for the use of such a factor. Instead, we recommend the use of dose-response modeling which would make LOAEL-to-NOAEL extrapolation redundant.
为了将亚慢性无观察到有害作用水平(NOAEL)外推至慢性NOAEL,通常应用10的不确定性系数。我们通过对一个包含149个口服NOAEL(亚慢性)/NOAEL(慢性)比值的数据库进行统计分析,对该不确定性系数进行了评估。由于任何数据库都只是所有现有化学品的有限样本,我们认为应该考虑估计误差。因此,除了比值分布的第95百分位数(P95)外,我们还计算了该百分位数的95%置信区间(CI)。几何均值(GM)、几何标准差(GSD)、P95和CI分别为1.7、5.6、29和20 - 46。这些数据并不支持如其他人所建议的降低不确定性系数。此外,我们分析了亚急性、亚慢性和慢性毒性研究的最低观察到有害作用水平(LOAEL)/NOAEL比值。然而,LOAEL/NOAEL比值的大小仅取决于所审查研究剂量之间的间距。因此,尽管结果可能被认为支持10的不确定性系数,但我们认为没有理由使用这样一个系数。相反,我们建议使用剂量反应模型,这将使从LOAEL到NOAEL的外推变得多余。